Our manufacturing complex in Hillerød consolidates all production-related operations and is a pivotal part of the company’s global manufacturing network. 

Leveraging our manufacturing excellence, we have gained a deep understanding of what it takes to consistently manufacture advanced biologics. Our manufacturing facility has a capacity of 90,000 liters to produce originator molecules and biosimilars of advanced biologics. Our facility for assembly, label and pack manufactures advanced delivery systems and ensures required labelling and secure packaging of the therapies for patients worldwide.

The Hillerød complex also houses quality control laboratories, warehouses, and a number of organizations, supporting the manufacturing activities: planning and purchasing, engineering, and quality assurance. The complex employs more than 650 people, representing more than 16 nationalities. 

Biogen’s investment in Hillerød of more than 4 billion DKK is the single largest foreign greenfield investment in Denmark. It includes construction of 8 buildings with more than 48,000 m2 under roof on the site of 247,000 m2 (60 acres). 

In 2013, Biogen earned AmCham’s Foreign Company Award in recognition for job creation and investment generated by the Hillerød complex. In 2015, Biogen in Hillerød received “Company of the Year” award by the regional business community C4.